Giant Hemifacial Fibrous Dysplasia Functional Treatment and Place of Pamidronate

J Craniofac Surg. 2017 May;28(3):706-708. doi: 10.1097/SCS.0000000000003640.

Abstract

The authors report the case of a 9-year-old child with severe form of hemifacial fibrous dysplasia. The authors review the pathology of this treatment modality through the case description and detail the place of pamidronate in the treatment of fibrous dysplasia.

Publication types

  • Case Reports

MeSH terms

  • Bone Density Conservation Agents / administration & dosage
  • Child
  • Diphosphonates / administration & dosage*
  • Dose-Response Relationship, Drug
  • Facial Bones*
  • Fibrous Dysplasia, Polyostotic / diagnosis
  • Fibrous Dysplasia, Polyostotic / therapy*
  • Follow-Up Studies
  • Humans
  • Imaging, Three-Dimensional
  • Injections, Intravenous
  • Male
  • Osteotomy / methods*
  • Pamidronate
  • Skull*
  • Tomography, X-Ray Computed / methods

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Pamidronate